European Journal of Nuclear Medicine and Molecular Imaging
Journal Abbreviation: EUR J NUCL MED MOL I
ISSN: 1619-7070
Publisher: Springer Verlag (Germany)
Publications (77)
Hybrid PET/MR imaging for the prediction of left ventricular recovery after percutaneous revascularisation of coronary chronic total occlusions (2020)
Vitadello T, Kunze KP, Nekolla SG, Langwieser N, Bradaric C, Weis F, Cassese S, et al.
Journal article
A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients (2020)
Peeken JC, Shouman MA, Kroenke M, Rauscher I, Maurer T, Gschwend JE, Eiber M, Combs SE
Journal article
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy (2020)
Vogel MME, Kroeze SGC, Henkenberens C, Schmidt-Hegemann NS, Kirste S, Becker J, Burger IA, et al.
Journal article
Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study (2020)
Schmidt-Hegemann NS, Kroeze SGC, Henkenberens C, Vogel MME, Kirste S, Becker J, Burger IA, et al.
Journal article
Positive FAPI-PET/CT in a metastatic castration-resistant prostate cancer patient with PSMA-negative/FDG-positive disease (2020)
Khreish F, Rosar F, Kratochwil C, Giesel FL, Haberkorn U, Ezziddin S
Journal article
Integration of PET-imaging into radiotherapy treatment planning for low-grade meningiomas improves outcome (2020)
Kessel KA, Weber W, Yakushev I, Fischer H, Voglhuber T, Diehl C, Straube C, et al.
Journal article
New insights in the paradigm of upregulation of tumoral PSMA expression by androgen receptor blockade: Enzalutamide induces PSMA upregulation in castration-resistant prostate cancer even in patients having previously progressed on enzalutamide (2020)
Rosar F, Dewes S, Ries M, Schaefer A, Khreish F, Maus S, Bohnenberger H, et al.
Journal article
225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience (2020)
Khreish F, Ebert N, Ries M, Maus S, Rosar F, Bohnenberger H, Stemler T, et al.
Journal article
Correction to: Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA (European Journal of Nuclear Medicine and Molecular Imaging, (2019), 10.1007/s00259-019-04649-1) (2020)
Schmidkonz C, Krumbholz M, Atzinger A, Cordes M, Götz T, Prante O, Ritt P, et al.
Journal article, Erratum
Evaluation of a Highly-Automated Dosimetry Tool-Chain for Lu-177-Therapies (2019)
Ritt P, Cachovan M, Vija AH, Kuwert T
Conference contribution